trending Market Intelligence /marketintelligence/en/news-insights/trending/p7yw5oupyucrcymurmexxq2 content esgSubNav
In This List

Novan names board member

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Novan names board member

Morrisville, N.C.-based biotechnology company Novan Inc. appointed Eugene Sun to the board, effective Feb. 16.

Sun was CEO of Melinta Therapeutics from 2015 to 2017. He also served on the now-defunct U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee, a panel of infectious disease experts, from 2001 to 2007.